CA
NZ
UK
AU
IND
US
Market Movers:On Wednesday, the top gainers were Braiin Limited (+79.35%), followed by Larimar Therapeutics, Inc. (+61.25%). On the contrary, ODDITY Tech Ltd. (-49.21%), and MannKind Corporation (-36.82%) declined the most the same day.
Shares ofIonQ Inc.climbed more than 12% in pre-market trading after the company reported triple-digit revenue growth and issued stronger-than-expected 2026 guidance. The results triggered a broader rally across quantum computing equities, lifting peers such asRigetti Computing Inc.,D-Wave Quantum Inc., andQuantum Computing Inc..
Clear Secure Inc (NYSE:YOU) surged 38.54% to $46.37 (February 25, 2026), signaling renewed investor confidence in the biometric identity verification company.
Sigma Lithium Resources Corp (NASDAQ:SGML) gained 29.92% to $16.37 amid renewed optimism in lithium markets.
Nutanix Inc (NASDAQ:NTNX) surged 29.77% to $49.13, driven by strong investor reaction to business momentum.
NRx Pharmaceuticals Inc (NASDAQ:NRXPW) jumped 44.97% to $0.05 (February 25, 2026), making it one of the top percentage gainers among US-listed stocks. The sharp move has drawn attention from speculative biotech investors looking for high-risk, high-reward opportunities.
Key Takeaways (February 2026)Rolls-Royce (LON:RR)shares surged around 5% on 26 February 2026 amid strongdefence sectorsentiment, analyst optimism, and continued civil aerospace recovery.• Improving free cash flow anddividend growthexpectations remain major catalysts attracting investors globally.• Macro tailwinds including rising defence budgets and global aviation demand …
Reason for the RallyThe move likely reflects investor optimism around restructuring, cost management, or improved reimbursement trends in value-based healthcare.Given the stock’s depressed levels, short covering likely amplified gains.
Gold markets have regained attention after reports of concentrated call option positioning on the COMEX futures exchange, part of the CME Group. More than 11,000 December 2026 call contracts reportedly sit at strike prices between $15,000 and $20,000 per ounce.
Larimar Therapeutics (NASDAQ:LRMR) delivered one of the strongest single-session performances on the NASDAQ, rallying 61.2% to $5.95 on extraordinary trading volume of 81.03 million shares, representing a 10.49x relative volume spike. With amarket capitalizationof approximately $494.39 million (EODHD/Others data as of February 25, 2026), …
Please wait processing your request...